PGR
58
6
APH
65
4
MHK
46
3
AXP
64
4
CNX
75
6
ECL
57
3
AAPL
39
-3
TXT
59
6
MLM
58
-2
AON
49
2
BLK
69
3
NWSA
78
5
AVGO
32
7
CAT
59
4
CHRW
53
3
THC
67
2
FLR
60
4
CNP
44
5
PEG
50
4
MCO
67
3
PGR
58
6
APH
65
4
MHK
46
3
AXP
64
4
CNX
75
6
ECL
57
3
AAPL
39
-3
TXT
59
6
MLM
58
-2
AON
49
2
BLK
69
3
NWSA
78
5
AVGO
32
7
CAT
59
4
CHRW
53
3
THC
67
2
FLR
60
4
CNP
44
5
PEG
50
4
MCO
67
3
Financhill
Back

Sarepta Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
31

SRPT
Sarepta Therapeutics

Last Price:
124.62
Seasonality Move:
11.13%
Buy
57

CPRX
Catalyst Pharmaceuticals

Last Price:
22.98
Seasonality Move:
-2.02%
Sell
31
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.96. The Score for CPRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 46.43 Sell
Chaikin Money Flow: 728345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.8 - 128.94) Buy
Bollinger Bands (100): (123.42 - 147.2) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.46 Buy
Relative Strength Index (14 RSI): 63.99 Buy
Chaikin Money Flow: 627083 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.18 - 21.74) Buy
Bollinger Bands (100): (16.55 - 21.01) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 127.08 Sell
20-day SMA: 126 Sell
50-day SMA: 127.18 Sell
200-day SMA: 130.57 Sell
8-day EMA: 125.96 Sell
20-day EMA: 126.26 Sell
50-day EMA: 128.02 Sell
200-day EMA: 127.82 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.76 Buy
20-day SMA: 21.21 Buy
50-day SMA: 20.55 Buy
200-day SMA: 17.06 Buy
8-day EMA: 21.72 Buy
20-day EMA: 21.3 Buy
50-day EMA: 20.45 Buy
200-day EMA: 17.72 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):